Current Pharmaceutical Design
Title:Editorial (Thematic Issue: Rheumatology: An Evolutionary force in Biologics)
Volume: 21 Issue: 17
Author(s): Matthew A. Sleeman
Affiliation:
Export Options
About this article
Cite this article as:
Sleeman A. Matthew, Editorial (Thematic Issue: Rheumatology: An Evolutionary force in Biologics), Current Pharmaceutical Design 2015; 21 (17) . https://dx.doi.org/10.2174/1381612821999150313162300
DOI https://dx.doi.org/10.2174/1381612821999150313162300 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
28
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-VEGF Therapy for Retinal Vein Occlusions
Current Drug Targets Candidate Circulating Biomarkers for the Cardiovascular Disease Continuum
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Drug Metabolism Natural Products and their (Semi-)Synthetic Forms in the Treatment of Migraine: History and Current Status
Current Medicinal Chemistry The Role of Systemic Treatment and Radiotherapy in Malignant Mesothelioma
Current Respiratory Medicine Reviews Epigenetics: Relations to Disease and Laboratory Findings
Current Medicinal Chemistry Regenerative Therapies for Improving Myocardial Perfusion in Patients with Cardiovascular Disease: Failure to Meet Expectations but Optimism for the Future
Current Vascular Pharmacology Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
Current Cancer Drug Targets Impact of Hydration on Exercise Performance and Physiological Responses
Current Nutrition & Food Science Apoptosis in Atherosclerosis: Virtue or Vice
Current Cardiology Reviews Human Endotoxemia as a Model of Systemic Inflammation
Current Medicinal Chemistry Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Current Pharmaceutical Design Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis
Current Pharmaceutical Design Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review
Drug Delivery Letters Targeting JAK3 Tyrosine Kinase-Linked Signal Transduction Pathways with Rationally-Designed Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
Current Cancer Drug Targets Editorial [Hot Topic:Drug Targets in Ageing and Age-Associated Diseases (Executive Editors: C. Caruso and E. Jirillo)]
Current Pharmaceutical Design The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21)
Current Protein & Peptide Science Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Current Genomics TRP Channels in the Digestive System
Current Pharmaceutical Biotechnology